We are live on
!
Find out more
CMU
Carnegie Mellon University Portfolio holdings
AUM
$64.3M
1-Year Est. Return
35.71%
This Fund
S&P 500
This Quarter
Est. Return
-5.48%
1 Year Est. Return
-35.71%
3 Year Est. Return
+32.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$73.9M
AUM Growth
-$6.16M
(-7.7%)
Cap. Flow
-$1.74M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Duolingo
DUOL
|
+$1.02M |
| 2 |
Vera Therapeutics
VERA
|
+$693K |
| 3 |
NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
|
+$21.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 99.79% |
| 2 | Consumer Staples | 0.19% |
| 3 | Real Estate | 0.02% |
| 4 | Healthcare | 0% |
Similar funds
1M
LC
CIR
CPM
NIP
PFO
JAWA
HFCIV
Carnegie Mellon University's Q2 2024 Portfolio in Review
As of Q2 2024, Carnegie Mellon University held 6 positions worth $73.9M, down 7.7% from $80.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Carnegie Mellon University's Q2 2024 filing shows 1 reduced and 2 closed positions. The largest sale was Duolingo, an estimated $1.02M.
By sector, the portfolio is most concentrated in Technology at 100% of assets, up from 99% a quarter earlier, followed by Consumer Staples and Real Estate.
- Carnegie Mellon University's biggest Q2 2024 reduction was Duolingo, cutting an estimated $1.02M.
- Carnegie Mellon University fully exited Vera Therapeutics in Q2 2024, selling an estimated $693K.
- Carnegie Mellon University's ten largest holdings make up 100% of its $73.9M portfolio in Q2 2024.
- Carnegie Mellon University opened 0 new positions and closed 2 in Q2 2024.
- Carnegie Mellon University's portfolio value fell 7.7% quarter-over-quarter to $73.9M.
Based on Carnegie Mellon University's 13F filing for Q2 2024, filed 8 Aug 2024.